RecallDepth

Medtronic HMS PLUS, Hemostasis Management System. Medtronic, Inc., Cardiovascular Division, Moundsview, MN 55112. A microprocessor based, multichannel clot timing instrument with automated syringe handling for pipetting blood into single use cartridges. It performs in vitro heparin sensitivity evaluations, heparin assays, activated clotting times and platelet function evaluations.

This recall has been terminated (originally issued May 4, 2010).

Company
Medtronic Inc. Cardiac Rhythm Disease Managment
Recall Initiated
March 8, 2010
Posted
May 4, 2010
Terminated
December 31, 2011
Recall Number
Z-1537-2010
Quantity
508 US, 36 OUS
Firm Location
Saint Paul, MN
Official Source
View on FDA website ↗

Reason for Recall

The heparin assay controls may run longer than normal and in some cases, fail to give an acceptable result.

Distribution

Worldwide Distribution -- United States, International West (countries included in Western Europe and the Middle East), Australia and Canada.

Lot / Code Info

HMS Plus Catalog Number: 30514;  Heparin Assay Controls: 306-01POR, 306-02POR, 306-03POR, 306-04POR, 306-05POR and 306-09POR.

Root Cause

Process change control

Action Taken

Medtronic issued an "Urgent Medical Device Notification" letter dated March 8, 2010 addressed to "Dear Valued Customer" and was sent to three locations at each customer site: Risk Management, Cardiovascular Surgery and Clinical Laboratory-Point of Care. The letter described the product and the issue, provided instructions for control and patient testing. The customer was requested to return an enclosed certificate as proof of notification. For further information, contact your Medtronic Sales Representative or call 1-763-391-9915.

More recalls by Medtronic Inc. Cardiac Rhythm Disease Managment

View all recalls by this company →